Pure Global

"Haifong Biomedical" Edoxaban correction solution group - Taiwan Registration f04f8a1ae4e9e7e5d9cd0cdd67f9ca74

Access comprehensive regulatory information for "Haifong Biomedical" Edoxaban correction solution group in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number f04f8a1ae4e9e7e5d9cd0cdd67f9ca74 and manufactured by HYPHEN BioMed. The authorized representative in Taiwan is SYSMEX TAIWAN CO., LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
f04f8a1ae4e9e7e5d9cd0cdd67f9ca74
Registration Details
Taiwan FDA Registration: f04f8a1ae4e9e7e5d9cd0cdd67f9ca74
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

"Haifong Biomedical" Edoxaban correction solution group
TW: โ€œๆตทๅฅ‰็”Ÿ็‰ฉ้†ซๅญธโ€ Edoxaban ๆ กๆญฃๆถฒ็ต„
Risk Class 2

Registration Details

f04f8a1ae4e9e7e5d9cd0cdd67f9ca74

DHA05603466402

Company Information

France

Product Details

This product is lyophilized human plasma doped with different concentrations of Edoxaban for correction of Edoxaban measurement.

A Clinical chemistry and clinical toxicology

A.1150 Calibrated Products

QMS/QSD;; ่ผธๅ…ฅ

Dates and Status

Jun 15, 2021

Jun 15, 2026